345 related articles for article (PubMed ID: 30368569)
1. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis.
Ma B; Ren Y; Chen Y; Lian B; Jiang P; Li Y; Shang Y; Meng Q
Int J Colorectal Dis; 2019 Jan; 34(1):113-121. PubMed ID: 30368569
[TBL] [Abstract][Full Text] [Related]
2. Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response.
Yang J; Deng Q; Cheng Y; Fu Z; Wu X
World J Surg Oncol; 2024 Jan; 22(1):31. PubMed ID: 38273352
[TBL] [Abstract][Full Text] [Related]
3. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
[TBL] [Abstract][Full Text] [Related]
5. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
6. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
7. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liu S; Jiang T; Xiao L; Yang S; Liu Q; Gao Y; Chen G; Xiao W
Oncologist; 2021 Sep; 26(9):e1555-e1566. PubMed ID: 33987952
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.
Turner MC; Keenan JE; Rushing CN; Gulack BC; Nussbaum DP; Benrashid E; Hyslop T; Strickler JH; Mantyh CR; Migaly J
J Gastrointest Surg; 2019 Aug; 23(8):1614-1622. PubMed ID: 30635829
[TBL] [Abstract][Full Text] [Related]
10. No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT).
Sainato A; Cernusco Luna Nunzia V; Valentini V; De Paoli A; Maurizi ER; Lupattelli M; Aristei C; Vidali C; Conti M; Galardi A; Ponticelli P; Friso ML; Iannone T; Osti FM; Manfredi B; Coppola M; Orlandini C; Cionini L
Radiother Oncol; 2014 Nov; 113(2):223-9. PubMed ID: 25454175
[TBL] [Abstract][Full Text] [Related]
11. Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma.
Tay RY; Jamnagerwalla M; Steel M; Wong HL; McKendrick JJ; Faragher I; Kosmider S; Hastie I; Desai J; Tacey M; Gibbs P; Wong R
Clin Colorectal Cancer; 2017 Jun; 16(2):e45-e54. PubMed ID: 27825672
[TBL] [Abstract][Full Text] [Related]
12. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment.
Li JY; Huang XZ; Gao P; Chen XW; Song YX; Lv XE; Fu Y; Xiao Q; Wang ZN
Biomed Res Int; 2021; 2021():8852699. PubMed ID: 34337057
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
15. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
[TBL] [Abstract][Full Text] [Related]
16. [Controversies and progress in adjuvant chemotherapy for patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy].
Li XX; Li QG
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):594-596. PubMed ID: 31238639
[TBL] [Abstract][Full Text] [Related]
17. Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection.
Dossa F; Acuna SA; Rickles AS; Berho M; Wexner SD; Quereshy FA; Baxter NN; Chadi SA
JAMA Oncol; 2018 Jul; 4(7):930-937. PubMed ID: 29710274
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.
Petrelli F; Coinu A; Lonati V; Barni S
Int J Colorectal Dis; 2015 Apr; 30(4):447-57. PubMed ID: 25433820
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.
Fu XL; Fang Z; Shu LH; Tao GQ; Wang JQ; Rui ZL; Zhang YJ; Tian ZQ
Oncotarget; 2017 May; 8(21):34340-34351. PubMed ID: 28423720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
